{"disease":{"id":"takayasu-arteritis-tak","name":"takayasu arteritis tak"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06766552","title":"A Registry Study Assessing PRO, Dosing Patterns, and Safety of Vunakizumab in Patients With General Rheumatic Diseases.","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT07077304","title":"EACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular Diseases","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT07451665","title":"Efficacy and Safety of Vunakizumab and Ivarmacitinib in the Treatment of Active Takayasu's Arteritis","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":180,"lead_sponsor_name":"Chinese SLE Treatment And Research Group","has_results":false},{"nct_id":"NCT06807788","title":"Evaluation of Platelet Aggregability in Patients with Takayasu's Arteritis","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Jose Carlos Nicolau","has_results":false},{"nct_id":"NCT07351422","title":"Investigating Management, Perspectives and Attitudes Towards Care in Takayasu Arteritis","phase":"","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"University of Edinburgh","has_results":false},{"nct_id":"NCT07013838","title":"The Efficacy and Safety of Deucravacitinib in Takayasu's Arteritis","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":50,"lead_sponsor_name":"Chinese SLE Treatment And Research Group","has_results":false}],"total":6},"guidelines":[],"source":"Drug Landscape verified database"}